Base editing and prime editing are redefining what’s possible in genetic medicine. Pioneered by David Liu, these tools are now showing real patient impact, including a personalized therapy for baby KJ developed in under seven months. Read more: https://t.co/2G0f4cOX4Y

🌾 WALYs measure innovation’s true impact; on people & planet. With @apolloagri, smallholder farmers access tools to boost yields & resilience. By 2029:✅ 1.5M farmers ✅ 500K+ tons of food ✅ 390K WALYs = 2M people lifted from food insecurity. Learn more: https://t.co/qWiF9XeSKJ

The big idea at @eGenesisbio: producing transgenic animals to make organs more compatible with humans. A potentially huge milestone for science and patients. 🎥 Watch 👉 https://t.co/fsMMGkS4jY #Healthcare #Innovation

🌍 When the rain comes, they’re ready. Across Africa, smallholder farmers face climate challenges & limited access to tools. @apolloagri is changing that: delivering inputs, credit & training via tech that meets farmers where they are. 🎥 Watch: https://t.co/FOG8jFrjqL

What if there was a new way to address the organ shortage?@eGenesisbio is engineering pig organs to make them compatible with humans.The first #kidney #xenotransplant achieved in March marks a turning point in medicine.🎥 Watch the full video.

Rice sustains over half the world’s population yet faces growing climate risk. 🌾 Portfolio company @PairwisePL is partnering with the International Rice Research Institute to develop rice varieties with greater resilience, yield, and nutrition. 🔗 https://t.co/9Cs1GOerLn

🌾 Food security grows when farmers access tech that boosts yields & climate resilience. Meet Caroline, a smallholder farmer whose life changed with @apolloagri’s support. Curious how their tech works? Watch the story: https://t.co/FOG8jFrjqL

Portfolio company Fork & Good acquired Orbillion. 👏 Together, they’re building a cost-effective platform to deliver red meat products to food manufacturers across North America, Europe, Asia, and the Middle East. 🥩 Read more: https://t.co/JzZq9ocENs

75% of women diagnosed with breast cancer have no family history. AI could help uncover hidden risk patterns that traditional screening can’t see, shifting care from reaction to prevention. Read more 👉 https://t.co/F8BpmrDSXJ #HealthTech

Portfolio company Sudo Biosciences reports positive Phase 1 results for SUDO-550, an oral TYK2 inhibitor designed to reach the brain and target immune pathways driving diseases such as multiple sclerosis. 🔬 Learn more: https://t.co/N7H8MO8ZUp

📣 Hear from @njengatwo on how @apolloagri plans to reach 1.5M farmers by 2029, boost productivity by 70%, and grow 500K+ tons of food—enough to feed 5M people. 🌽 How will tech make it happen? Watch the full story: https://t.co/FOG8jFrjqL

AI is giving radiologists a new superpower: seeing risk before disease appears.FDA-authorized tools like Clairity Breast analyze subtle patterns to predict a woman’s five-year breast cancer https://t.co/2i1WvBmKma more 👉 https://t.co/RQdAIVlohc

🌱 Food security starts with inclusion. @apolloagri gives smallholder farmers in Kenya & Zambia access to modern ag tools for better harvests. 🌽Co-founder @EliPollak explains how. Watch the full video to learn more: https://t.co/FOG8jFrjqL

Our new video features @apolloagri, an agri-#fintech platform empowering smallholder #farmers in Africa. By 2029, Apollo aims to reach 1.5M farmers, close yield gaps & raise productivity by 70%; producing 500K tons of food, enough to feed 5M people: https://t.co/4iSPppDOX0

From daily pills to one-time cures? 💊 Statins save millions but aren’t curative. Verve & nChroma are testing genome-based approaches to lower cholesterol with a single intervention. Full story: Juergen Eckhardt in @Forbes: https://t.co/Mmqjm3vl6m

From managing HIV to curing it at scale? Antiretrovirals save lives but don’t end the virus. Now breakthroughs in antibodies, mRNA & novel therapies are bringing a scalable cure into view. Read Juergen Eckhardt’s Forbes op-ed 👉 https://t.co/QKV5kanbNT

🌎 This is for the kids and grandkids. Sustainability isn’t just strategy. It’s personal – for Denise Boehme, Ingo Kloeckner, Nicki Saee, and the whole team at Leaps by Bayer.

🚶‍➡️Articulating #impact vs. measuring it. Watch Juergen Eckhardt, Ingo Koeckner and Nicki Saee talk about why we need to go beyond #SDGs to measure the impact of our investments in healthcare. Want to learn how to measure impact? https://t.co/bmPJRReSoN

Hot take: It’s not impact or #ROI – it’s both!Nicki Saee, Digital Marketing Manager at Leaps, breaks down one of the biggest misconceptions about impact investing, why ESG metrics don’t suffice, and what it takes to measure what truly matters. #ESG #impact #impactmeasurement

Let’s get to the meat of the matter. Who is open to trying cultivated meat? More importantly, why? Explore what we found with @BCG and @IpsosUK in our latest survey: https://t.co/3DXFDGjKLK